Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Psoriasis Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
AstraZeneca
Novartis
Eli Lilly
Amgen
Celgene
Johnson & Johnson
By Type:
Interleukin-inhibitors
Others
TNF-inhibitors
By Application:
Hospital
Clinic
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Psoriasis Drugs Market Overview 2018-2029
-
1.1 China Psoriasis Drugs Industry Development Overview
-
1.2 China Psoriasis Drugs Industry Development History
-
1.3 China Psoriasis Drugs Industry Market Size (2018-2029)
-
1.4 China Psoriasis Drugs Market Analysis by Type from Production Side
-
1.4.1 China Psoriasis Drugs Production Volume, Production Value and Growth Rate of Interleukin-inhibitors (2018-2029)
-
1.4.2 China Psoriasis Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Psoriasis Drugs Production Volume, Production Value and Growth Rate of TNF-inhibitors (2018-2029)
-
1.5 China Psoriasis Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Psoriasis Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Psoriasis Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.6 China Psoriasis Drugs Market Analysis by Region
-
1.6.1 North China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Psoriasis Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Psoriasis Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Psoriasis Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Psoriasis Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Psoriasis Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Psoriasis Drugs Industry Development
Chapter 3 Psoriasis DrugsIndustry Chain Analysis
-
3.1 Psoriasis Drugs Industry Chain
-
3.2 Psoriasis Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Psoriasis Drugs Market
-
3.3 Psoriasis Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Psoriasis Drugs Market
Chapter 4 China Psoriasis Drugs Market, by Type
-
4.1 China Psoriasis Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Psoriasis Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Psoriasis Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Psoriasis Drugs Production Volume and Growth Rate of Interleukin-inhibitors
-
4.5.2 China Psoriasis Drugs Production Volume and Growth Rate of Others
-
4.5.3 China Psoriasis Drugs Production Volume and Growth Rate of TNF-inhibitors
Chapter 5 China Psoriasis Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Psoriasis Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Psoriasis Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Psoriasis Drugs Market Size and Growth Rate of Hospital
-
5.5.2 China Psoriasis Drugs Market Size and Growth Rate of Clinic
Chapter 6 China Psoriasis Drugs Market, by Region
-
6.1 China Psoriasis Drugs Production Volume and Production Value, by Region
-
6.2 China Psoriasis Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Psoriasis Drugs Market Analysis
-
7.1 North China Psoriasis Drugs Market, by Type
-
7.2 North China Psoriasis Drugs Market, by Application
Chapter 8 Central China Psoriasis Drugs Market Analysis
-
8.1 Central China Psoriasis Drugs Market, by Type
-
8.2 Central China Psoriasis Drugs Market, by Application
Chapter 9 South China Psoriasis Drugs Market Analysis
-
9.1 South China Psoriasis Drugs Market, by Type
-
9.2 South China Psoriasis Drugs Market, by Application
Chapter 10 East China Psoriasis Drugs Market Analysis
-
10.1 East China Psoriasis Drugs Market, by Type
-
10.2 East China Psoriasis Drugs Market, by Application
Chapter 11 Northeast China Psoriasis Drugs Market Analysis
-
11.1 Northeast China Psoriasis Drugs Market, by Type
-
11.2 Northeast China Psoriasis Drugs Market, by Application
Chapter 12 Southwest China Psoriasis Drugs Market Analysis
-
12.1 Southwest China Psoriasis Drugs Market, by Type
-
12.2 Southwest China Psoriasis Drugs Market, by Application
Chapter 13 Northwest China Psoriasis Drugs Market Analysis
-
13.1 Northwest China Psoriasis Drugs Market, by Type
-
13.2 Northwest China Psoriasis Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Profile
-
14.1.2 AstraZeneca Psoriasis Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Novartis
-
14.2.1 Novartis Company Profile
-
14.2.2 Novartis Psoriasis Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Eli Lilly
-
14.3.1 Eli Lilly Company Profile
-
14.3.2 Eli Lilly Psoriasis Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Amgen
-
14.4.1 Amgen Company Profile
-
14.4.2 Amgen Psoriasis Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Celgene
-
14.5.1 Celgene Company Profile
-
14.5.2 Celgene Psoriasis Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Profile
-
14.6.2 Johnson & Johnson Psoriasis Drugs Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Psoriasis Drugs Industry Research Conclusions
-
15.2 Psoriasis Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Psoriasis Drugs Industry Market Size (2018-2029)
-
Figure China Psoriasis Drugs Production Volume, Production Value and Growth Rate of Interleukin-inhibitors (2018-2029)
-
Figure China Psoriasis Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Psoriasis Drugs Production Volume, Production Value and Growth Rate of TNF-inhibitors (2018-2029)
-
Figure China Psoriasis Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Psoriasis Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure North China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Psoriasis Drugs Market Size and Growth Rate from 2018-2029
-
Figure Psoriasis Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Psoriasis Drugs Market Share by Type in 2018
-
Figure China Psoriasis Drugs Market Share by Type in 2023
-
Figure China Psoriasis Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Psoriasis Drugs Production Volume and Growth Rate of Interleukin-inhibitors (2018-2023)
-
Figure China Psoriasis Drugs Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Psoriasis Drugs Production Volume and Growth Rate of TNF-inhibitors (2018-2023)
-
Figure China Psoriasis Drugs Market Share by Application in 2018
-
Figure China Psoriasis Drugs Market Share by Application in 2023
-
Figure China Psoriasis Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Psoriasis Drugs Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Psoriasis Drugs Market Size and Growth Rate of Clinic (2018-2023)
-
Table China Psoriasis Drugs Production Volume by Region (2018-2023)
-
Table China Psoriasis Drugs Production Volume Share by Region (2018-2023)
-
Figure China Psoriasis Drugs Production Volume Share by Region (2018-2023)
-
Table China Psoriasis Drugs Production Value by Region (2018-2023)
-
Table China Psoriasis Drugs Production Value Share by Region (2018-2023)
-
Figure China Psoriasis Drugs Production Value Share by Region (2018-2023)
-
Table China Psoriasis Drugs Sales Volume by Region (2018-2023)
-
Table China Psoriasis Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Psoriasis Drugs Sales Volume Share by Region (2018-2023)
-
Table China Psoriasis Drugs Sales Value by Region (2018-2023)
-
Table China Psoriasis Drugs Sales Value Share by Region (2018-2023)
-
Figure China Psoriasis Drugs Sales Value Share by Region (2018-2023)
-
Table North China Psoriasis Drugs Production Volume by Type (2018-2023)
-
Table North China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Table North China Psoriasis Drugs Sales Volume by Application (2018-2023)
-
Table North China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Psoriasis Drugs Production Volume by Type (2018-2023)
-
Table Central China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Psoriasis Drugs Sales Volume by Application (2018-2023)
-
Table Central China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Psoriasis Drugs Production Volume by Type (2018-2023)
-
Table South China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Table South China Psoriasis Drugs Sales Volume by Application (2018-2023)
-
Table South China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Psoriasis Drugs Production Volume by Type (2018-2023)
-
Table East China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Table East China Psoriasis Drugs Sales Volume by Application (2018-2023)
-
Table East China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Psoriasis Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Psoriasis Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Psoriasis Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Psoriasis Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Psoriasis Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Psoriasis Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Psoriasis Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Psoriasis Drugs Sales Volume Share by Application (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Psoriasis Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Psoriasis Drugs Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Psoriasis Drugs Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Psoriasis Drugs Revenue, Price and Gross (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene Psoriasis Drugs Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Psoriasis Drugs Revenue, Price and Gross (2018-2023)
-
